We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.
Breaking News
Introducing Infex Therapeutics
The organisation leading UK efforts to tackle the health crisis around our dwindling supply of effective antibiotics is broadening its focus to include infectious disease – and has today unveiled a…
Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award
The AMR Centre has combined forces to attract much needed investment to combat the global threat of antimicrobial resistance (AMR) resulting in a successful bid for a £114 million project supported…
The AMR Centre signs agreement to co-develop treatment for gonorrhoea
The AMR Centre (AMRC) has today announced a multi-year co-development agreement with Massachusetts-based clinical stage biopharmaceutical company Microbiotix, Inc. to progress a novel treatment to…
Latest News
Introducing Infex Therapeutics
The organisation leading UK efforts to tackle the health crisis around our dwindling…
Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award
The AMR Centre has combined forces to attract much needed investment to combat the global…
The AMR Centre signs agreement to co-develop treatment for gonorrhoea
The AMR Centre (AMRC) has today announced a multi-year co-development agreement with…
More People in the United States Dying from Antibiotic-Resistant Infections than Previously Estimated
Significant progress since 2013 could be lost without more action
AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes
The AMR Centre has nominated a preclinical candidate in its program that tackles drug…
The AMR Centre set for partnership with Shionogi for new superbug therapy
The AMR Centre Ltd has today announced a landmark agreement with the Japanese pharma…
AMR Centre to join first life sciences delegation to Biomed in Israel
The North’s life sciences landscape will be showcased on an international stage at a…
The AMR Centre secures £2.3m funding boost
The AMR Centre has received a significant funding package to support the expansion of its…